We're Not Worried About Castle Biosciences' (NASDAQ:CSTL) Cash Burn

Yahoo FinanceApr 17 19:06

Castle Biosciences(CSTL.US) Officer Sells US$106.02K in Common Stock

$Castle Biosciences(CSTL.US)$ Officer MAETZOLD DEREK J sold 5,210 shares of common stock on Apr 12, 2024 at an average price of $20.35 for a total value of $106.02K.Source: Announcement What is statem

Futu NewsApr 17 05:29

Form 144 | Castle Biosciences(CSTL.US) Officer Proposes to Sell 381.3K in Common Stocks

SEC FILLINGS DISCLOSED/ Apr 12, $Castle Biosciences(CSTL.US)$ Officer Derek Maetzold intends to sell 19,008 shares of its common stock on Apr 12, with a total market value of approximately $381.3K.

Futu NewsApr 13 04:40

Castle Biosciences to Release First Quarter 2024 Financial Results and Host Conference Call on Thursday, May 2, 2024

Castle Biosciences, Inc. (NASDAQ:CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter ended March 31, 2024,

BusinesswireApr 11 19:00

Castle Biosciences(CSTL.US) Director Sells US$49,087.2 in Common Stock

$Castle Biosciences(CSTL.US)$ Director BRADBURY DANIEL sold 2,400 shares of common stock on Apr 8, 2024 at an average price of $20.453 for a total value of $49,087.2.Source: Announcement What is state

Futu NewsApr 11 05:16

Castle Biosciences Celebrates Esophageal Cancer Awareness Month Through Advocacy and Educational Collaborations

Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, recognizes the importance of Esophageal Cancer Awareness Month and is providing its support of key programs and initiatives throughout the month of April.

BusinesswireApr 11 05:00